RE:Two Business Lines & Key Progress Updates Between CRH and MYHEALTH that adds up to >$40M per year in 2022 from CRH in FCF >$20M per year from MYHEALTH whch means >$60M per year of FCF in 2022 just from these 2 acquisitions. This is the first quarter we get a full contribution from the MYHEALTH segment to WELL's earnings.
There was no mention of 2 other substantial businesses that were tucked in and contributed for most of the 3rd quarter and we are about to hear about them in the next week or 2.
Remember Circle Medicine? On September 30th there was a news release of revenue growth of 275% up to $20M per year. I am not sure how much FCF was possible with that rate of growth but at some point there will be positive FCF.
WISP also will report almost a full quarter of their resutls on WELLs book last quarter and they were projected to add $30M in revenue run rate per year as well with positive EBITA.. Here again their is no mention of FCF in the previous press release but I think positive EBITA usually indicates that there may be some positive FCF as well.
This is all adding up to a significant uptick in WELL's revenues. It is rather clear that the WELL team is also hitting their goal of creating significant FCF to finance further endeavors in future lucrative acquisitions.
They seem to be doing a very good job of the 3 things that make any successful enterprise. They are spending less than they make. They own more than they owe and they have a plan that they are executing in the way that they said they would.
At some point in time, the trading price of this stock will move forward with this sort of progress in the value of this company. You don't really know when that is going to happen. (Look at Tesla this month). In the meantime, those with the investment attention span of a gnat will have their time to play. When the stock shoots up to its proper valueation they will pay dearly.